ANDERSEN JAN T ET AL: "Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues", FEBS JOURNAL, vol. 275, no. 16, August 2008 (2008-08), pages 4097-4110, XP002629972, ISSN: 1742-464X (B1)

WO-A2-2007/021494 (B1)

ANDERSEN JAN TERJE ET AL: "The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics.", DRUG METABOLISM AND PHARMACOKINETICS, vol. 24, no. 4, 10 September 2009 (2009-09-10), pages 318-332, XP002629974, ISSN: 1880-0920 (B1)

CARLSON J ET AL: "ALLOALBUMINEMIA IN SWEDEN STRUCTURAL STUDY AND PHENOTYPIC DISTRIBUTION OF NINE ALBUMIN VARIANTS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 89, no. 17, 1992, pages 8225-8229, XP002629977, ISSN: 0027-8424 (B1)

CHAUDHURY CHAITY ET AL: "Albumin binding to FcRn: distinct from the FcRn-IgG interaction.", BIOCHEMISTRY, vol. 45, no. 15, 18 April 2006 (2006-04-18), pages 4983-4990, XP002629973, ISSN: 0006-2960 (B1)

DATABASE UniProt [Online] 24 July 2007 (2007-07-24), "SubName: Full=Uncharacterized protein;", XP002629970, retrieved from EBI accession no. UNIPROT:A6NBZ8 Database accession no. A6NBZ8 (B1)

ISHIMA YU ET AL: "S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 320, no. 3, 1 March 2007 (2007-03-01) , pages 969-977, XP002510092, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US ISSN: 0022-3565, DOI: 10.1124/JPET.106.114959 (B1)

IWAO ET AL: "Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS & PROTEOMICS, vol. 1774, no. 12, 1 December 2007 (2007-12-01), pages 1582-1590, XP022385158, ELSEVIER, NETHERLANDS ISSN: 1570-9639, DOI: 10.1016/J.BBAPAP.2007.09.001 (B1)

IWAO Y ET AL: "Oxidation of Arg-410 promotes the elimination of human serum albumin", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS & PROTEOMICS, ELSEVIER, vol. 1764, no. 4, 1 April 2006 (2006-04-01), pages 743-749, XP025123234, ISSN: 1570-9639, DOI: 10.1016/J.BBAPAP.2006.01.011 [retrieved on 2006-04-01] (B1)

KENANOVA V. ET AL: "HSA Domain III as a protein scaffold with defined serum pharmacokinetics", THE JOURNAL OF NUCLEAR MEDICINE , vol. 50, no. Suppl. 2 15 May 2009 (2009-05-15), XP002629971, Retrieved from the Internet: URL:http://jnumedmtg.snmjournals.org/cgi/c ontent/meeting_abstract/50/2_MeetingAbstra cts/1582 [retrieved on 2011-03-22] (B1)

KENANOVA VANIA E ET AL: "Tuning the serum persistence of human serum albumin domain III: diabody fusion proteins", PROTEIN ENGINEERING DESIGN & SELECTION, vol. 23, no. 10, October 2010 (2010-10), pages 789-798, XP002629975, ISSN: 1741-0126 (B1)

KRAGH-HANSEN U ET AL: "Effect of genetic variation on the thermal stability of human serum albumin", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS & PROTEOMICS, vol. 1747, no. 1, 14 February 2005 (2005-02-14), pages 81-88, XP004725430, ELSEVIER, NETHERLANDS ISSN: 1570-9639, DOI: 10.1016/J.BBAPAP.2004.09.025 (B1)

MINCHIOTTI LORENZO ET AL: "Mutations and polymorphisms of the gene of the major human blood protein, serum albumin", HUMAN MUTATION, vol. 29, no. 8, 1 August 2008 (2008-08-01) , pages 1007-1016, XP002520020, JOHN WILEY & SONS, INC, US ISSN: 1059-7794, DOI: 10.1002/HUMU.20754 (B1)

OLAFSEN TOVE ET AL: "Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment", NATURE PROTOCOLS, NATURE PUBLISHING GROUP, GB, vol. 1, no. 4, 1 January 2006 (2006-01-01) , page 2048, XP001537674, ISSN: 1750-2799, DOI: DOI:10.1038/NPROT.2006.322 (B1)

SHEFFIELD W P ET AL: "Modulation of clearance of recombinant serum albumin by either glycosylation or truncation.", THROMBOSIS RESEARCH, vol. 99, no. 6, 15 September 2000 (2000-09-15), pages 613-621, XP002616651, ISSN: 0049-3848 (B1)

US-A1- 2006 051 859 (B1)

WO-A1-2004/011499 (B1)

WO-A1-95/23857 (B1)

ANDERSEN JAN TERJE ET AL: "A receptor-mediated mechanism to support clinical observation of altered albumin variants.", CLINICAL CHEMISTRY, vol. 53, no. 12, December 2007 (2007-12), page 2216, XP002629976, ISSN: 0009-9147 (B1)